Moneycontrol PRO

HomeNewsDavid redfern

David Redfern

Jump to

See long-term potential in Indian market: GSK Plc

CNBC-TV18 spoke with David Redfern, Chief Strategy Officer, GlaxoSmithKline plc, to discuss the open offer, the subsidiary‘s current state of the business and its plans.
GSK raises stake in Indian consumer unit

GlaxoSmithKline has lifted its stake in its publicly-listed Indian consumer healthcare subsidiary to 72.5 percent from 43.2 percent, deepening its footprint in emerging markets and non-prescription products.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347